Christopher D Conrady1, Jonathan A Feistmann2, Aaron B Roller3, H Culver Boldt4, Akbar Shakoor1. 1. Department of Ophthalmology, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah. 2. Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York. 3. Texas Retina Institute, Round Rock, Texas. 4. Department of Ophthalmology, University of Iowa, Iowa City, Iowa.
Abstract
PURPOSE: To describe a case series of postintravitreal injection, bacterial endophthalmitis heralded by hemorrhagic retinal vasculitis. METHODS: Observational case series of three patients with a history of intravitreal injections for age-related macular degeneration at a tertiary referral center who presented with vision changes and eye pain that were eventually found to have bacterial endophthalmitis. Clinical course was then followed. RESULTS: All patients developed bacterial endophthalmitis and hemorrhagic retinal vasculitis. CONCLUSION: These three cases highlight the importance of hemorrhagic retinal vasculitis as the presenting fundus finding of bacterial endophthalmitis and that this finding in a postinjection patient should be treated as endophthalmitis until proven otherwise.
PURPOSE: To describe a case series of postintravitreal injection, bacterial endophthalmitis heralded by hemorrhagic retinal vasculitis. METHODS: Observational case series of three patients with a history of intravitreal injections for age-related macular degeneration at a tertiary referral center who presented with vision changes and eye pain that were eventually found to have bacterial endophthalmitis. Clinical course was then followed. RESULTS: All patients developed bacterial endophthalmitis and hemorrhagic retinal vasculitis. CONCLUSION: These three cases highlight the importance of hemorrhagic retinal vasculitis as the presenting fundus finding of bacterial endophthalmitis and that this finding in a postinjection patient should be treated as endophthalmitis until proven otherwise.